Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Author： Shurin Michael R   Gregory Melissa   Morris John C   Malyguine Anatoli M  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.11, 2010-11, pp. : 1539-1553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically modified dendritic cells – a new, promising cancer treatment strategy?

By Wysocki PJ   Grabarczyk P   Mackiewicz-Wysocka M   Kowalczyk DW   Mackiewicz A  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 835-845

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell immunotherapy for breast cancer

By Pinzon-Charry Alberto   Schmidt Chris   López José Alejandro  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 591-604

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell fusion vaccines for cancer immunotherapy

By Rosenblatt Jacalyn   Kufe Donald   Avigan David  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 703-715

Informa Healthcare

Access to resources Recommend Favorite

Immunoregulatory T cells in cancer immunotherapy

By Morse Michael A   Clay Timothy M   Mosca Paul   Lyerly H Kim  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 827-834

Informa Healthcare

Access to resources Recommend Favorite

Natural killer–dendritic cell cross-talk in cancer immunotherapy

By Kalinski Pawel   Mailliard Robbie B   Giermasz Adam   Zeh Herbert J   Basse Per   Bartlett David L   Kirkwood John M   Lotze Michael T   Herberman Ronald B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1303-1315

Informa Healthcare

Access to resources Recommend Favorite